Spicing Up Cancer Prevention

Findings offer insight on curcumin's cancer-preventing activity

January 25, 2011 | Leigh MacMillan


Curcumin – the active ingredient that flavors curries and gives the Indian spice turmeric its yellow color – is being studied for its ability to prevent tumor development. Its efficacy, however, is limited by chemical and metabolic instability. Previous studies have focused on the non-enzymatic (not mediated by a protein) cleavage of curcumin into smaller fragments.

Claus Schneider, Ph.D., and colleagues have now characterized a new pathway for the metabolism of curcumin. They report in the Jan. 14 Journal of Biological Chemistry that curcumin undergoes an oxidation reaction – either spontaneously or mediated by the protein COX-2 – to form a different chemical structure. They showed that the oxidation pathway is preferred to the cleavage pathway in mouse macrophage-like cells.

They also found that the pathway generates an intermediate compound – a reactive chemical called a quinone methide. Because anti-cancer drugs with chemical components (phenol rings) like curcumin work by forming quinone methides, the findings suggest that the oxidative transformation of curcumin may contribute to its cancer-preventing activity.

For other research highlights from Vanderbilt University Medical Center laboratories, see ‘Aliquots‘ in the VUMC Reporter.

No Comments

No comments yet.

Sorry, the comment form is closed at this time.